It is not scheduled as a controlled substance by the DEA and is not explicitly named in the Designer Anabolic Steroid Control Act of 2014, though federal prosecutors have pursued unapproved-new-drug and misbranding cases against vendors marketing peptides for human performance use
In occlusion/occlusion-like syndromes affecting both periphery and brain (portal hypertension, caval hypertension, intracranial hypertension), BPC-157 simultaneously normalized blood pressure disturbances, healed gastrointestinal and liver lesions, minimized brain lesions and hemorrhage, prevented thrombosis, and preserved neurological function
(PubMed) Bosch AM, Abeling NG, Ijlst L, et al
Its important to understand how IGF-1 LR3 differs from peptides like Ipamorelin/Sermorelin and CJC-1295
Are you looking to support your natural skin glow from within